inhaled colistimethate sodium (ProMIS Neurosciences)
90
Structured Review
ProMIS Neurosciences
inhaled colistimethate sodium
Inhaled Colistimethate Sodium, supplied by ProMIS Neurosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/colistimethate+sodium/colistimethate+sodium/pm40101950-26-4-1
Average 90 stars, based on 1 article reviews
Inhaled Colistimethate Sodium, supplied by ProMIS Neurosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/colistimethate+sodium/colistimethate+sodium/pm40101950-26-4-1
Average 90 stars, based on 1 article reviews
inhaled colistimethate sodium - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Infection:Article Title: Pulmonary Delivery of Antibiotics to the Lungs: Current State and Future Prospects. Article Snippet: .. A phase III trial, PROMIS-I, suggested a clinical benefit of Article Title: Pulmonary Delivery of Antibiotics to the Lungs: Current State and Future Prospects Article Snippet: .. A phase III trial, PROMIS-I, suggested a clinical benefit of other:Article Title: Inhaled colistimethate sodium in patients with bronchiectasis and Pseudomonas aeruginosa infection: results of PROMIS-I and PROMIS-II, two randomised, double-blind, placebo-controlled phase 3 trials assessing safety and efficacy over 12 months Article Snippet: Findings 377 patients were randomly assigned in Article Title: Inhaled colistimethate sodium in patients with bronchiectasis and Pseudomonas aeruginosa infection: results of PROMIS-I and PROMIS-II, two randomised, double-blind, placebo-controlled phase 3 trials assessing safety and efficacy over 12 months Article Snippet: In Article Title: Inhaled colistimethate sodium in patients with bronchiectasis and Pseudomonas aeruginosa infection: results of PROMIS-I and PROMIS-II, two randomised, double-blind, placebo-controlled phase 3 trials assessing safety and efficacy over 12 months Article Snippet: In Article Title: Inhaled colistimethate sodium in patients with bronchiectasis and Pseudomonas aeruginosa infection: results of PROMIS-I and PROMIS-II, two randomised, double-blind, placebo-controlled phase 3 trials assessing safety and efficacy over 12 months Article Snippet: In Article Title: Inhaled colistimethate sodium in patients with bronchiectasis and Pseudomonas aeruginosa infection: results of PROMIS-I and PROMIS-II, two randomised, double-blind, placebo-controlled phase 3 trials assessing safety and efficacy over 12 months Article Snippet: Given the results of PROMIS-I, there was a less than 1 in 2000 |